| Myra Frances Barginear, | |
|
15 Manitou Rd, Westport, CT 06880-6008 | |
| (203) 293-4208 | |
| Not Available |
| Full Name | Myra Frances Barginear |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Medical Oncology |
| Location | 15 Manitou Rd, Westport, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467607283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RX0202X | Internal Medicine - Medical Oncology | 237364 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Myra Frances Barginear, 15 Manitou Rd, Westport, CT 06880-6008 Ph: (203) 293-4208 | Myra Frances Barginear, 15 Manitou Rd, Westport, CT 06880-6008 Ph: (203) 293-4208 |
News Archive
Cyclacel Pharmaceuticals, Inc. today announced that six abstracts highlighting translational and preclinical data for Cyclacel's cell cycle inhibitor drugs have been selected for presentation at the American Association of Cancer Research (AACR) Annual Meeting, being held from April 17-21, 2010, in Washington, DC.
Food poisoning is a scourge. Yet preventing it is far from foolproof. But in a new study in Analytical Chemistry, scientists report that they are closing in on a way to use a combination of color-changing paper and electrochemical analysis - on plastic transparency sheets or simple paper - to quickly, cheaply and more accurately detect bacterial contamination of fruits and vegetables in the field before they reach grocery stores, restaurants and household pantries.
Meda has in-licensed exclusive rights to Ceplene (histamine dihydrochloride) from EpiCept Corporation, a US-based biopharmaceutical company.
With the first of the baby boomer generation now entering their eighties, the next decade will see a significant increase in the number of people living with osteoporosis and experiencing the often devastating outcome of fragility fractures.
Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).
› Verified 7 days ago
Jay A Horn, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 333 Post Rd W, Westport, CT 06880 Phone: 203-226-0731 | |
Dr. Boris V Sheynberg, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 32 Imperial Ave, Westport, CT 06880 Phone: 203-226-1760 Fax: 203-221-8291 | |
Dr. Steven W Ryder, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 4 Ambler Rd W, Westport, CT 06880 Phone: 203-695-7933 | |
Dr. Samuel Frumkin, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 162 Kings Hwy N, Westport, CT 06880 Phone: 203-226-0731 Fax: 203-226-1792 | |
Dr. Robban Ariel Sica, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: C/o West Port Integrative Medicine, Llc Suite 100, 1 Turkey Hill Road South, Westport, CT 06880 Phone: 203-799-7733 Fax: 203-987-4853 | |
Deborah A. Mayer, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 131 Kings Hwy N Ste 2, Westport, CT 06880 Phone: 203-557-8347 Fax: 203-557-8349 | |
Cristina Roxana Ionescu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Post Rd W, Westport, CT 06880 Phone: 203-226-0731 Fax: 203-226-1792 |